Back to search
Long QT Syndrome Type 3
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Long QT Syndrome Type 3 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Long QT Syndrome Type 3 trials you may qualify forThe goal of this clinical trial is to learn whether the study drug THRV-1268 can safely and effectively shorten the QT interval in people diagnosed with Long QT…
This is a cross-sectional observational study designed to assess the disease burden and quality of life in individuals with LQTS 2 and 3. Each participant will…
Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…
In patients expressing the SCN5A-E1784K mutation (Glu1784Lys), cardiovascular risk is difficult to define as the stratification of these patients is challenging…
Part 1: This is a Phase 1b, randomized, double-blind, crossover, dose escalation, placebo-controlled study to evaluate the effect of oral LQT-1213 on dofetilide…